Literature DB >> 10516019

Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base.

D A Einfeld1, D E Brough, P W Roelvink, I Kovesdi, T J Wickham.   

Abstract

Modification of adenovirus to achieve tissue specific targeting for the delivery of therapeutic genes requires both the ablation of its native tropism and the introduction of specific, novel interactions. Inactivation of the native receptor interactions, however, would cripple the virus for growth in production cells. We have developed an alternative receptor, or pseudoreceptor, for the virus which might allow propagation of viruses with modified fiber proteins that no longer bind to the native adenovirus receptor (coxsackievirus/adenovirus receptor [CAR]). We have constructed a membrane-anchored single-chain antibody [m-scFv(HA)] which recognizes a linear peptide epitope (hemagglutinin [HA]). Incorporation of HA within the HI loop of the fiber protein enabled the modified virus to transduce pseudoreceptor expressing cells under conditions where fiber-CAR interaction was blocked or absent. The pseudoreceptor mediated virus transduction with an efficiency similar to that of CAR. In addition, the HA epitope mediated virus transduction through interaction with the m-scFv(HA) when it was introduced into penton base. These findings indicate that cells expressing the pseudoreceptor should support production of HA-tagged adenoviruses independent of retaining the fiber-CAR interaction. Moreover, they demonstrate that high-affinity targeting ligands may function following insertion into either penton base or fiber.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516019      PMCID: PMC112945     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies.

Authors:  T J Wickham; D M Segal; P W Roelvink; M E Carrion; A Lizonova; G M Lee; I Kovesdi
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

Authors:  C Defer; M T Belin; M L Caillet-Boudin; P Boulanger
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.

Authors:  L K Gilliland; N A Norris; H Marquardt; T T Tsu; M S Hayden; M G Neubauer; D E Yelton; R S Mittler; J A Ledbetter
Journal:  Tissue Antigens       Date:  1996-01

5.  Characterization of adenovirus particles made by deletion mutants lacking the fiber gene.

Authors:  B Falgout; G Ketner
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

6.  Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment.

Authors:  P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.

Authors:  S Huang; T Kamata; Y Takada; Z M Ruggeri; G R Nemerow
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

9.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.

Authors:  J Field; J Nikawa; D Broek; B MacDonald; L Rodgers; I A Wilson; R A Lerner; M Wigler
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  Covalently closed circles of human adenovirus DNA are infectious.

Authors:  F L Graham
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  19 in total

1.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types.

Authors:  Clare E Thomas; Penny Edwards; Thomas J Wickham; Maria G Castro; Pedro R Lowenstein
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein.

Authors:  Natalya Belousova; Valentina Krendelchtchikova; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Authors:  Raul Alba; Angela C Bradshaw; Lynda Coughlan; Laura Denby; Robert A McDonald; Simon N Waddington; Suzanne M K Buckley; Jenny A Greig; Alan L Parker; Ashley M Miller; Hongjie Wang; Andre Lieber; Nico van Rooijen; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

6.  Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.

Authors:  Anja Krause; Ju H Joh; Neil R Hackett; Peter W Roelvink; Joseph T Bruder; Thomas J Wickham; Imre Kovesdi; Ronald G Crystal; Stefan Worgall
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.

Authors:  Ijad Madisch; Soeren Hofmayer; Christian Moritz; Alexander Grintzalis; Jens Hainmueller; Patricia Pring-Akerblom; Albert Heim
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.

Authors:  Jin Kim; Theodore Smith; Neeraja Idamakanti; Kathy Mulgrew; Michele Kaloss; Helen Kylefjord; Patricia C Ryan; Michael Kaleko; Susan C Stevenson
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.

Authors:  J L Jakubczak; M L Rollence; D A Stewart; J D Jafari; D J Von Seggern; G R Nemerow; S C Stevenson; P L Hallenbeck
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Adenoviral vectors for improved gene delivery to the inner ear.

Authors:  Mark Praetorius; Douglas E Brough; Chi Hsu; Peter K Plinkert; Susanna C Pfannenstiel; Hinrich Staecker
Journal:  Hear Res       Date:  2008-12-07       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.